FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Artificial Intelligence Platform Aiding Drug Reviews: Report

A GCN report says FDA is relying on the Abbyy digital intelligence platform to analyze and summarize drug safety reports.

Medical Devices

Abbott Covid Test EUA Includes Asymptomatic Use

FDA grants Abbott an Emergency Use Authorization for over-the-counter, non-prescription, asymptomatic use of its BinaxNow Covid-19 Ag Self Test for de...

Human Drugs

Apotex Recalls 3 Lots of Guanfacine Extended-Release Tablets

FDA says Apotex is recalling three lots of Guanfacine extended-release tablets after finding contamination in one lot.

Human Drugs

Sanofis Sarclisa Expanded OK in Multiple Myeloma

FDA approves Sanofis Sarclisa (isatuximab) for combination use with carfilzomib and dexamethasone in treating adult patients with relapsed or refracto...

Federal Register

Editorial Changes Made Due to Obsolete FDA Office

Federal Register notice: FDA amends its medical device regulations to make an editorial nonsubstantive change and replace a reference to an obsolete o...

Federal Register

Panel to Discuss BLA for Type 1 Diabetes

Federal Register notice: FDA announces a 5/27 Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss a Provention Bio BLA for eplizu...

Federal Register

2-Day FDA Science Forum in May

Federal Register notice: FDA announces a 5/26-27 workshop entitled FDA Science Forum 2021.

Federal Register

Technical Corrections for Drug Import Entries

Federal Register notice: FDA amends its electronic import entries regulation to correct the statutory citation in the sections of that regulation requ...

Medical Devices

CDRH Medical Device Development Tools Help Developers: Shuren

CDRH director Jeffrey Shuren describes the Centers Medical Device Development Tools program and Catalog of Regulatory Science Tools.

Human Drugs

Advisory Committee Aducanumab Deliberations Explained

Three university experts say their advisory committee experience with Biogens aducanumab shows the value in randomized clinical trials that patients a...